--Novartis announced today that the US Food and Drug Administration has approved Xolair ® for the reduction of allergic reactions, including anaphylaxis, that may occur with accidental exposure to one ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today new positive data from Stage 2 and Stage 3 of the National Institutes ...
Add Yahoo as a preferred source to see more of our stories on Google. Chances are, you may know a family living with food allergies. Food allergies are more prevalent than many realize, particularly ...
Add Yahoo as a preferred source to see more of our stories on Google. In all, 36% of children treated with omalizumab (Xolair) for a year successfully ate full servings of allergy-triggering foods, ...
Please provide your email address to receive an email when new articles are posted on . The campaign follows the approval of Xolair for the reduction of allergic reactions after accidental exposure.
CLEVELAND, Ohio — For those with severe food allergies, the simple act of eating can pose a serious health threat. Many patients, and parents, live in real fear of a serious allergic reaction, and ...
The US Food and Drug Administration (FDA) has approved omalizumab injection (Xolair, Genentech) for children aged 1 year or older and adults to reduce immunoglobulin E─mediated severe allergy to ...
An injectable drug used for decades to treat asthma substantially reduced potentially life-threatening reactions in children with an allergy who were exposed to trace amounts of peanuts, eggs, milk ...
Xolair is a brand-name prescription medication and is a biologic. Its active ingredient is called omalizumab. Generic versions of biologic medications are called biosimilars. Due to complex ...
PISCATAWAY, N.J.--(BUSINESS WIRE)--Kashiv BioSciences, LLC today announced the completion of patient enrollment for its Phase III clinical trial of ADL018, a biosimilar candidate to XOLAIR®. This ...
– Xolair is the only U.S. FDA-approved medicine to reduce allergic reactions in children and adults with one or more food allergies – SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Genentech, a member ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results